Javascript on your browser is disabled. Please enable it for better performance of ETHealthworld.
As per IMS sales data, Gleevec had annual sales of around $2 billion in the US.
New Delhi, Aug 20 : Drug major Lupin today said it has received approval from the US health regulator to market generic fenofibrate tablets, used to treat high cholesterol, in the American market.
The company has received final approval from the US Food and Drug Administration (USFDA) to market generic version of Teva's Fenofibrate tablets in strengths of 54mg and 160mg, Lupin said in a statement.
The Mumbai-based company's US unit, Lupin Pharmaceuticals Inc would commence promoting the product shortly in the US, it added.
According to IMS MAT June data, fenofibrate tablets in strengths of 54 mg and 160 mg had US sales of USD 156 million.
Lupin has close to 20 per cent market share of the overall US Fenofibrate market. The drug firm now has a total of 81 products in the US market.
The Anna University team presented a perfect example of symbiosis, as professors of biotechnology, medical electronics, manufacturing, electronics and communication engineering, instrumentation and medical physics joined hands.
Scientists discover a mutation in a previously unidentified gene in a Scottish woman. They hope to leverage this to make a new painkiller.
The EconomicTimes.com privacy and cookie policy has been updated to align with the new data regulations in European Union. Please review and accept these changes below to continue using the website.
You can see our privacy policy & our cookie list below. We use cookies to ensure the best experience for you on our website.
If you choose to ignore this message, we'll assume that you are happy to receive all cookies on ET HealthWorld.
Google Analytics Google 1 Year HTTPS To track visitors to the site, their origin & behaviour.
Promo Mailers Receive information about events, industry, etc.
Privacy Policy / Terms & Conditions / Guest-Post Guidelines / Sitemap / Copyright © 2019 ETHealthworld.com . All Rights Reserved.
